Cabaletta Bio, Inc. (CABA)
1.585
+0.06
(+4.28%)
USD |
NASDAQ |
Oct 29, 16:00
1.57
-0.02
(-0.95%)
After-Hours: 05:13
Cabaletta Bio Price to Book Value : 1.262 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.262 |
| October 28, 2026 | 1.211 |
| October 27, 2026 | 1.159 |
| October 26, 2026 | 1.075 |
| October 23, 2026 | 1.171 |
| October 22, 2026 | 1.211 |
| October 21, 2026 | 1.226 |
| October 20, 2026 | 1.282 |
| October 19, 2026 | 1.179 |
| October 16, 2026 | 1.123 |
| October 15, 2026 | 1.234 |
| October 14, 2026 | 1.290 |
| October 13, 2026 | 1.346 |
| October 12, 2026 | 1.426 |
| October 09, 2026 | 1.537 |
| October 08, 2026 | 1.553 |
| October 07, 2026 | 1.569 |
| October 06, 2026 | 1.609 |
| October 05, 2026 | 1.657 |
| October 02, 2026 | 1.593 |
| October 01, 2026 | 1.505 |
| September 30, 2026 | 1.529 |
| September 29, 2026 | 1.577 |
| September 28, 2026 | 1.593 |
| September 25, 2026 | 1.649 |
| Date | Value |
|---|---|
| September 24, 2026 | 1.716 |
| September 23, 2026 | 1.768 |
| September 22, 2026 | 1.991 |
| September 21, 2026 | 1.959 |
| September 18, 2026 | 2.031 |
| September 17, 2026 | 2.055 |
| September 16, 2026 | 1.983 |
| September 15, 2026 | 2.067 |
| September 14, 2026 | 2.318 |
| September 11, 2026 | 2.174 |
| September 10, 2026 | 2.182 |
| September 09, 2026 | 2.318 |
| September 08, 2026 | 2.604 |
| September 04, 2026 | 2.764 |
| September 03, 2026 | 2.772 |
| September 02, 2026 | 2.843 |
| September 01, 2026 | 2.628 |
| August 31, 2026 | 2.477 |
| August 28, 2026 | 2.485 |
| August 27, 2026 | 2.692 |
| August 26, 2026 | 2.588 |
| August 25, 2026 | 2.565 |
| August 24, 2026 | 2.469 |
| August 21, 2026 | 2.493 |
| August 20, 2026 | 2.541 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.31 |
| Anika Therapeutics, Inc. | 2.124 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.9278 |
Price to Book Value Related Metrics
| Price | 1.585 |
| Earnings Yield | -99.80% |
| Market Cap | 265.85M |